Robert Hawkins, MD, discussed an updated risk calculator—and the latest data on SAVR after TAVR—for a new video interview with Cardiovascular Business.
While the Trump administration is pushing to accelerate clinical AI adoption, SCAI has emphasized that physicians must guide how the technology is implemented and governed.
Serious complications are rare after TAVR, but they can be catastrophic or fatal when they do occur. The care team at Sentara Heart Hospital found that bringing in new 3D software made it much easier to plan ahead for such issues.
The introduction of a 3D pediatric transesophegeal echo probe is having a major impact on how these pediatric congenital heart patients are being treated.
The efficiency adjustment cuts introduced in the 2026 MPFS are based on assumptions many doctors believe to be false. The American Society of Nuclear Cardiology and other medical societies are pushing back.